I don’t know about you, but these market swings are definitely making me dizzy! Tariffs, inflation, the reemergence of recession fears—are all serving to rattle investors.

This morning’s inflation report, however, did push us into somewhat positive territory, with February’s CPI rising 0.2% (2.8%, annually), a bit less than the 0.3% forecast and considerably better than the 0.5% rise in January.

Also, on the good news front, mortgage rates have finally begun to decline, with the average 30-year interest rate now at 6.72%.

The great rebalancing is unfolding as we expected with the S&P 500 struggling while other global markets are gaining traction. The performance gap between U.S. and international equities so far this year is the largest since 2017.

With that in mind, today we add a new recommendation outside U.S. borders - albeit a company whose bread and butter is the U.S. market. It’s the best of both worlds.

Details inside.

This is the worst market we’ve seen in a while. And the ugliness could last a while.

Tariff talk is all the rage. The economy is slowing. Nobody is sure about inflation or interest rates. It all adds uncertainty. The market had been riding high for more than two years. A comeuppance has arrived. How long will it last and how deep will it be?

During times of maximum uncertainty like this, healthcare stocks are a great place to be. That was the topic of last month’s exquisitely crafted issue. But there is another industry with both defensive and growth characteristics that’s ideal for uncertain times – garbage.

We live in the garbage capital of the world. This country generated 292 million tons of waste in 2018, up from 251 tons in 2012, and nearly double the waste produced in 1980. That’s enough waste to produce a pile long enough to go to the moon and back – 29 times. And that’s every single year. Waste services are big business. In 2023, the U.S. waste management services industry generated $145 billion in revenue. That was up from $137 billion the prior year and that number is likely to keep rising.

Garbage will continue to pile up regardless of where interest rates go, the level of economic growth, or the fallout from tariffs. The market could soar, or the world could go to Hell in a handbag. Either way my wife will nag me every week to take out the garbage.

Bank on a company with certain earnings and revenue in uncertain times. Defensive stocks tend to outperform during and after volatile markets. In this issue, I highlight a company that is the unquestioned leader in waste services. The stock has a strong track record which could get even better in the years ahead.

The selling pressures of the past two weeks continued last week as traders grappled with tariff concerns, a possibly slowing economy, and growth stocks again falling dramatically. By week’s end the S&P 500 had lost 3.1%, the Dow had fallen 2.4%, and the Nasdaq had dropped another 3.5%. The selling only worsened on Monday, with all three indexes down more than 2%.

What we’ve seen since the February 19 top in growth stocks has basically been a rolling crash, with most every leading stock from 2024 breaking its intermediate-term uptrend. Now, short-term, we do think things are finally getting hairy—recession fears and tariff headlines are making the rounds even as we are seeing a few near-term rays of light (the number of stocks hitting new lows is actually drying up a bit). That might be a reason to hold a some smaller positions at a profit, but overall, we remain clearly defensive. Our Market Monitor is now at a level 3, though we’re most interested in seeing how strong and persistent any bounce is once it begins.

This week’s list has names from all over the map, though medical and foreign stocks certainly dominate the list. Our Top Pick is a mid-cap biotech that has booming sales and earnings, and the stock is strong.

The market is melting down with no end in sight. The question is, does this more closely resemble the July/August carry trade/weak jobs report selling of last year, when the major indexes fell an almost identical amount to what they have in the past three weeks? Or are we hurtling toward the end of the 28-month bull market? We may know the answer soon, as the all-important February inflation prints are released later this week.

In the meantime, we’re playing plenty of defense in today’s issue, selling out of six of our positions that have completely broken down, and adding shares of a low-risk gold miner that’s been a favorite of Cabot Explorer Chief Analyst Carl Delfeld for some time.

Details inside.

The selling pressures of the past two weeks continued last week as traders grappled with tariff concerns, a possibly slowing economy, and growth stocks again falling dramatically. By week’s end the S&P 500 had lost 3.1%, the Dow had fallen 2.4%, and the Nasdaq had dropped another 3.5%.

The selling pressures of the past two weeks continued last week as traders grappled with tariff concerns, a possibly slowing economy, and growth stocks again falling dramatically. By week’s end the S&P 500 had lost 3.1%, the Dow had fallen 2.4%, and the Nasdaq had dropped another 3.5%.

After a huge run and a choppy two-month stretch, the sellers have taken control and are crushing most stocks, especially growth titles, many of which broken down and--for the big winners of last year--are flashing abnormal action. With our Cabot Tides, Two-Second Indicator and Aggression Index firmly negative, we’re mostly on the sideline and are content to wait things out until the next uptrend gets underway.

Encouragingly, though, there are still a good number of fresher growth stocks (got going in the last two or three months) that are taking the selling in stride; upside will be limited for now, of course, but tonight we have an expanded watch list of names that could be new leaders down the road. Eventually, the sun will shine again, but for now it’s best to focus mostly on capital preservation, which will allow us to make that much more money when the bulls are back.

Today’s addition is a profitable small-cap MedTech company specializing in products to treat peripheral nerve injuries.

Management has a number of growth-oriented irons in the fire. And I think the company could be an attractive acquisition target.

While the sock has been relatively stable in this increasingly volatile market, we’ll still start with a half-sized position, just in case.

U.S. markets are in a tailspin, and previously hard-charging growth stocks are leading the slide. But two asset classes that have often been overlooked in recent years are off to very good starts in 2025: value stocks and European stocks. Having just “retired” a European value stock that reached our price target in last week’s update, today we add a Dutch-based mid-cap with an almost identical profile – but at a time when undervalued European stocks are getting treated like U.S. growth stocks.

Details inside.

For the second straight week growth stocks got hit hard, which weighed on the Nasdaq. Though interestingly, as money rotated out of the 2024 leaders, it raced into slow and steady stocks that have been left behind in years past. By week’s end the S&P 500 had lost 1%, the Dow had gained 1%, and the Nasdaq had fallen 3.5%.

Explorer stocks had a good week, but I wanted to highlight that recently, Warren Buffett sold almost 400 million of Apple (AAPL) stock during the second quarter. The Oracle of Omaha sold about 390 million shares of Apple stock, reducing Berkshire Hathaway’s ownership to roughly 400 million shares.

Granted, Berkshire booked some giant investment gains during the second quarter, with Apple accounting for a big share of those winnings. This is nothing to sneeze at, but why did Buffett and company decide to sell the shares, thereby missing out on some big capital gains? Forbes notes that Apple’s average closing price in the second quarter was 186, which is well below the 226 at which the stock closed on August 20.

The success of headliners Walmart and Target in the last week has helped drive consumer staples stocks as a group up nearly 5% in August. No other S&P 500 sector has performed better this month. And yet, consumer staples are “only” up 14% year to date, trailing the gains in the S&P 500 (17.3%).

Thus, the sector as a whole is still undervalued. That spells opportunity.

What a difference two weeks make! From the close on Monday, August 7 to the close on Monday, August 14, the S&P 500 was up about 8% and is again flirting with the high.

The market fell a lot from mid-July to early August. But it has since recovered all the losses. While the S&P is back near the high, the last month has been a wild ride to nowhere. Now what?

What recession? After a terrible start to August, the market has completely turned around. The S&P 500 has moved 7.5% higher since August 5 and is again near the high.

The recession fears that contributed to the worst day for the market in over a year were overblown. And numbers have come out since that indicate a recession is unlikely any time soon. But the Fed is still expected to start slashing rates next month. It looks like we will still get the rate cuts without a recession. The market loves it.

In today’s note, we discuss the recent earnings reports from Berkshire Hathaway (BRKB), B2Gold (BTG) and Kopin (KOPN), among others. We’re also making a new addition to the portfolio in the form of YETI Holdings (YETI).

WHAT TO DO NOW: The market’s rebound has been very encouraging, especially when looking at individual growth names—we’re seeing more constructive action now than we were during the narrow advance of June and July, including among all of our holdings. That said, the intermediate-term trend for most everything is still neutral at best (negative for lots of stuff), so the possibility of a partial or full retest still exists. Given our large cash position, we’re going to add half-sized positions tonight in Palantir (PLTR) and Axon Enterprises (AXON), two strong potential leading titles, but we’ll also still hold a 50%-ish cash position as we watch to see how things play out from here. Details below.

With this week’s PPI inflation number (Tuesday morning) coming in lower than expected and the CPI reading (Wednesday morning) coming in as expected, the trend of lower inflation remains intact.

That’s a good thing, unless you have a hankering to buy more Treasuries and have held off.

The 2-year Treasury yield is now below 4%.

Inflation is dead.

OK, it’s not “dead.” But at 2.9% in July, as reported Wednesday morning, it has now (narrowly) reentered the Federal Reserve’s magical 2% realm for the first time in nearly three and a half years – since March 2021. For all the inflation angst during those past three and a half years, the market has fared pretty well overall – the S&P 500 is up 30% since the first CPI print north of 3% was reported in mid-May of 2021. On a per-year basis, that only slightly trails the average annual return in the large-cap index of 9.9% since its inception in 1928.

The cannabis sector has a dream ticket with Kamala Harris and Tim Walz. Investors act like they haven’t even noticed. This seems like a big mistake.

The key takeaway: Cannabis stocks look buyable in the current bout of dramatic sector weakness. Cannabis investors are notoriously bipolar. Right now, they are in a dark mood. That’s usually been the best time to add to positions, especially when there are potential catalysts on the horizon like now. In today’s update, I outline the main ones and the possible timing.

Isn’t this fun? The market gave us whiplash last week. The crash last Monday was the worst day for the market in years. It seemed like the sky was falling. But investors sobered up and the market closed flat for the week.

The tumult of last week was just a noisy road to nowhere. But the market also again showed great vulnerability to negative headlines. And while all that recession talk last week seems to have been clearly overblown, a recession is on the radar now. The market is resilient as usual. But don’t get too comfortable.

In today’s note, we discuss the recent earnings reports from Nokia (NOK) and Newell Brands (NWL), plus 15 other earnings reports from portfolio companies, some of which impacted their standing in the portfolio. Busy week, so let’s get into it.

What a wild couple of weeks.

For two weeks after the June 11 CPI print, small-cap stocks were advancing at such a record pace that they were finally being talked about again in the financial media.

Everything seemed great through the Fed meeting last Wednesday.

Then the wheels came off.

We are recommending shares of CNH Industrial (CNHI) as a new Buy. The company is a major producer of agriculture (80% of sales) and construction (20% of sales) equipment for customers around the world and is the #2 ag equipment producer in North America (behind Deere). It also provides related supplies, services and financing.

Okay, it’s time to start rolling the remainder of our February 16 short calls. I’m going to start with our GLD position in All-Weather and then move on to the Yale Endowment Portfolio followed by the various Dogs of the Dow Portfolios.

Shares of Shopify (SHOP) are giving up last week’s gains (plus a little) today after the company reported Q4 results before the market opened. Revenue growth of 24.5% to $2.16 billion was solid (beat by 3.7%) as was Gross Merchandise Value (GMV) growth of 23% (roughly 10 points faster than broad eCommerce growth) and adjusted EPS of $0.34 ($0.04 better than expected).

WHAT TO DO NOW: Hold some cash and take things on a stock-by-stock basis. The market is getting whacked today as inflation remains higher than expected, which has interest rates rallying sharply and expectations of Fed rate cuts sliding. That said, the trends of most indexes and stocks are still fine, and with 30% in cash coming into today, we’re not overreacting—but we will sell one-third of our Arista Networks (ANET) position, which is one of many tech names getting whacked after a good-not-great quarterly report, while placing PulteGroup (PHM) on Hold. That will leave us with around 33% in cash, which we’ll hang on to as we see how this pullback plays out.

I’m selling more call premium in GDX today. We’ve reaped most of the call premium from our February 16, 2024, 29 calls so I’m going to buy them back and sell more premium going out to the March expiration.

Shares of Pinterest (PINS) are selling off today after Q4 earnings came in slightly below expectations (food and beverage weakness a culprit), though the big-picture story remains one of a company that’s made a number of operational adjustments and launched a series of growth initiatives that should drive higher revenue and EPS growth in 2024. I think the recovery story is intact and the stock’s worth owning. Keeping at buy half.

As I stated yesterday, I’ll be rolling our February expiration short call positions into March expiration over the next few days. Moreover, per usual this time of year, I’ll be selling our LEAPS in the passive portfolios (All-Weather and Yale Endowment) at March expiration and buying new LEAPS going out to the January 2026 expiration.

I’ll be sending out alerts for several of our Fundamentals portfolios over the next several days, most likely stretching into early next week, as we stay mechanical and roll our February 16, 2024, calls into various March expiration cycles.

Intapp (INTA) is down about 10% today (downside move wipes out January gain and puts stock at support near 40) after reporting Q2 fiscal 2024 results. I don’t love the reaction but think this will prove to be “noise” and that INTA remains a supremely compelling stock to own.

I will be exiting our Amgen (AMGN) trade today. I will discuss the trade in greater detail in our upcoming weekly issue and within our subscriber-only call this Friday.

Amgen (AMGN) is due to announce earnings today after the closing bell.

A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.

A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.